Cargando…

AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity

BACKGROUND: In mammals, the AKT/PKB protein kinase family comprises three members (AKT1–3). PI3-Kinase (PI3K), a key oncogene involved in a wide variety of cancers, drives AKT activity. Constitutive activation of the PI3K/AKT pathway has been associated with tumorigenic properties including uncontro...

Descripción completa

Detalles Bibliográficos
Autores principales: Brolih, Sanja, Parks, Scott K., Vial, Valérie, Durivault, Jérôme, Mostosi, Livio, Pouysségur, Jacques, Pagès, Gilles, Picco, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836445/
https://www.ncbi.nlm.nih.gov/pubmed/29506489
http://dx.doi.org/10.1186/s12885-018-4169-0
_version_ 1783303969760608256
author Brolih, Sanja
Parks, Scott K.
Vial, Valérie
Durivault, Jérôme
Mostosi, Livio
Pouysségur, Jacques
Pagès, Gilles
Picco, Vincent
author_facet Brolih, Sanja
Parks, Scott K.
Vial, Valérie
Durivault, Jérôme
Mostosi, Livio
Pouysségur, Jacques
Pagès, Gilles
Picco, Vincent
author_sort Brolih, Sanja
collection PubMed
description BACKGROUND: In mammals, the AKT/PKB protein kinase family comprises three members (AKT1–3). PI3-Kinase (PI3K), a key oncogene involved in a wide variety of cancers, drives AKT activity. Constitutive activation of the PI3K/AKT pathway has been associated with tumorigenic properties including uncontrolled cell proliferation and survival, angiogenesis, promotion of cellular motility, invasiveness and metastasis. However, AKT1 activity has also been recently shown to repress the invasive properties of breast cancer cells in specific contexts. METHODS: This study used both pharmacological and shRNA approaches to inhibit AKT function, microscopy to characterize the cellular morphology, 3D spheroid models to assess migratory and invasive cellular capacities and a phenotypic screening approach based on electrical properties of the cells. RESULTS: Here we demonstrate that the alternative action of AKT1 on invasive properties of breast cancers can be extended to head and neck carcinomas, which exhibit constitutive activation of the PI3K/AKT pathway. Indeed, inhibition of AKT1 function by shRNA or a specific pharmacological inhibitor resulted in cellular spreading and an invasive phenotype. A phenotypic screening approach based on cellular electrical properties corroborated microscopic observations and provides a foundation for future high-throughput screening studies. This technique further showed that the inhibition of AKT1 signaling is phenocopied by blocking the mTORC1 pathway with rapamycin. CONCLUSION: Our study suggests that the repressive action of PI3K/AKT1 on cellular invasive properties may be a mechanism common to several cancers. Current and future studies involving AKT inhibitors must therefore consider this property to prevent metastases and consequently to improve survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4169-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5836445
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58364452018-03-07 AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity Brolih, Sanja Parks, Scott K. Vial, Valérie Durivault, Jérôme Mostosi, Livio Pouysségur, Jacques Pagès, Gilles Picco, Vincent BMC Cancer Research Article BACKGROUND: In mammals, the AKT/PKB protein kinase family comprises three members (AKT1–3). PI3-Kinase (PI3K), a key oncogene involved in a wide variety of cancers, drives AKT activity. Constitutive activation of the PI3K/AKT pathway has been associated with tumorigenic properties including uncontrolled cell proliferation and survival, angiogenesis, promotion of cellular motility, invasiveness and metastasis. However, AKT1 activity has also been recently shown to repress the invasive properties of breast cancer cells in specific contexts. METHODS: This study used both pharmacological and shRNA approaches to inhibit AKT function, microscopy to characterize the cellular morphology, 3D spheroid models to assess migratory and invasive cellular capacities and a phenotypic screening approach based on electrical properties of the cells. RESULTS: Here we demonstrate that the alternative action of AKT1 on invasive properties of breast cancers can be extended to head and neck carcinomas, which exhibit constitutive activation of the PI3K/AKT pathway. Indeed, inhibition of AKT1 function by shRNA or a specific pharmacological inhibitor resulted in cellular spreading and an invasive phenotype. A phenotypic screening approach based on cellular electrical properties corroborated microscopic observations and provides a foundation for future high-throughput screening studies. This technique further showed that the inhibition of AKT1 signaling is phenocopied by blocking the mTORC1 pathway with rapamycin. CONCLUSION: Our study suggests that the repressive action of PI3K/AKT1 on cellular invasive properties may be a mechanism common to several cancers. Current and future studies involving AKT inhibitors must therefore consider this property to prevent metastases and consequently to improve survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4169-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-05 /pmc/articles/PMC5836445/ /pubmed/29506489 http://dx.doi.org/10.1186/s12885-018-4169-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Brolih, Sanja
Parks, Scott K.
Vial, Valérie
Durivault, Jérôme
Mostosi, Livio
Pouysségur, Jacques
Pagès, Gilles
Picco, Vincent
AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
title AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
title_full AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
title_fullStr AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
title_full_unstemmed AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
title_short AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
title_sort akt1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active pi3 kinase activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836445/
https://www.ncbi.nlm.nih.gov/pubmed/29506489
http://dx.doi.org/10.1186/s12885-018-4169-0
work_keys_str_mv AT brolihsanja akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT parksscottk akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT vialvalerie akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT durivaultjerome akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT mostosilivio akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT pouyssegurjacques akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT pagesgilles akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity
AT piccovincent akt1restrictstheinvasivecapacityofheadandneckcarcinomacellsharboringaconstitutivelyactivepi3kinaseactivity